Financials

Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 当前
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Editas Medicine, Inc. - Common Stock

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

新闻